86 related articles for article (PubMed ID: 9387517)
41. In vitro maintenance of a new ovarian cancer cell line in protein-free media: a potential model for autonomous growth and tumor progression.
Golombick T; Bezwoda WR
Eur J Cell Biol; 1991 Dec; 56(2):459-63. PubMed ID: 1802727
[TBL] [Abstract][Full Text] [Related]
42. [Gonadotropins stimulate the proliferation of human epithelial ovarian cancer cell].
Feng Y; Zhang X; Ge B
Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):166-8. PubMed ID: 8758792
[TBL] [Abstract][Full Text] [Related]
43. [Synergism in the stimulating effect of transforming growth factor beta and insulin on the substrate-independent proliferation of the CHO-719 cell line].
Sushel'nitskiĭ SI; Iakimovich IA; Stoĭka RS; Kusen' SI
Tsitologiia; 1993; 35(8):47-51. PubMed ID: 8266574
[TBL] [Abstract][Full Text] [Related]
44. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.
Mills GB; May C; McGill M; Roifman CM; Mellors A
Cancer Res; 1988 Mar; 48(5):1066-71. PubMed ID: 3422589
[TBL] [Abstract][Full Text] [Related]
45. [The regulation of the secretion of transforming growth factor-beta 1 by estrogen on ovarian cancer AO, 3AO cell lines and its relationship with cell proliferation].
Dai J; Feng Y; Yang Y
Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):736-9. PubMed ID: 9387516
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor beta 1 (TGF-beta 1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors.
Jozan S; Guerrin M; Mazars P; Dutaur M; Monsarrat B; Cheutin F; Bugat R; Martel P; Valette A
Int J Cancer; 1992 Nov; 52(5):766-70. PubMed ID: 1330935
[TBL] [Abstract][Full Text] [Related]
47. Regulation of metastatic ovarian cells in serum-free medium by epidermal growth factor and transferrin.
Turner JT; Wyche JH
J Cell Physiol; 1980 Aug; 104(2):233-40. PubMed ID: 6967873
[No Abstract] [Full Text] [Related]
48. [The effects of growth factors on gene expressions in human ovarian cancer cell line HO-8910].
Chen X; Dai H; Wei L
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):351-5. PubMed ID: 9387273
[TBL] [Abstract][Full Text] [Related]
49. [Establishment of a new human ovarian serous cystadenocarcinoma cell line (IM), and influence on cell proliferations by cisplatin with or without hyperthermia].
Iida T; Yoshida N; Kuramoto H; Shimoda T; Hamano M; Hata H; Yonamine K; Hayashi K
Hum Cell; 1996 Dec; 9(4):345-52. PubMed ID: 9183668
[TBL] [Abstract][Full Text] [Related]
50. Effects of transforming growth factor-beta on the production of parathyroid hormone-related peptide in a human ovarian cancer cell line in vitro.
Yasui T; Uemura H; Irahara M; Aono T
J Obstet Gynaecol Res; 1997 Jun; 23(3):231-8. PubMed ID: 9255034
[TBL] [Abstract][Full Text] [Related]
51. [Autocrine transforming growth factor-beta stimulates human ovarian cancer cell growth in vitro and in vivo].
Xiong S; Chen Y; Wu A
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):22-4. PubMed ID: 8758814
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of human ovarian cancer cell proliferation by calmodulin inhibitors and the possible mechanism.
Kikuchi Y; Miyauchi M; Nagata I
Gynecol Oncol; 1989 Nov; 35(2):156-8. PubMed ID: 2807005
[TBL] [Abstract][Full Text] [Related]
53. Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth.
Wimalasena J; Dostal R; Meehan D
Gynecol Oncol; 1992 Sep; 46(3):345-50. PubMed ID: 1326473
[TBL] [Abstract][Full Text] [Related]
54. On deciding which factors regulate cell growth.
Pardee AB; Cherington PV; Medrano EE
Prog Clin Biol Res; 1981; 66 Pt A():495-502. PubMed ID: 7031686
[TBL] [Abstract][Full Text] [Related]
55. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.
Wilson AP; Fox H; Scott IV; Lee H; Dent M; Golding PR
Br J Cancer; 1991 Jan; 63(1):102-8. PubMed ID: 1989647
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of human ovarian cancer cell proliferation in vitro by neuroendocrine hormones.
Kikuchi Y; Kita T; Miyauchi M; Iwano I; Kato K
Gynecol Oncol; 1989 Jan; 32(1):60-4. PubMed ID: 2521212
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory effects of neuroendocrine hormones on human ovarian cancer cell proliferation in vitro.
Kikuchi Y; Kita T; Miyauchi M; Oomori K; Kizawa I; Iwano I; Kato K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1653-4. PubMed ID: 3479504
[No Abstract] [Full Text] [Related]
58. Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites.
Hurteau J; Rodriguez GC; Whitaker RS; Shah S; Mills G; Bast RC; Berchuck A
Cancer; 1994 Jul; 74(1):93-9. PubMed ID: 8004589
[TBL] [Abstract][Full Text] [Related]
59. [Production of CA125 in cell lines derived from human ovarian carcinoma: in relation to the cell cycle].
Suzuki M; Ma J; Usui N; Furugen Y; Takada M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):710-6. PubMed ID: 1506733
[TBL] [Abstract][Full Text] [Related]
60. The heterogeneous proliferation of human cancer cells in vivo.
Post J; Sklarew RJ
Pathol Annu; 1985; 20 Pt 1():359-81. PubMed ID: 3887298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
